CurrentCommunity Health Plan WashingtonPolicy MC.CP.MP.184

Home Ventilators

Defines medical necessity criteria for initial and continued use of noninvasive and invasive home ventilators for Medicare members/enrollees, including indications (restrictive thoracic disorders, COPD, overlap syndromes), requirements for backup/second ventilators, and coding implications (E0465-E0468).

Policy Summary

PayerCommunity Health Plan Washington

PolicyHome Ventilators

Policy CodePolicy MC.CP.MP.184

Change TypeCoding and references updated

Effective Date

Next Review Date

Key ActionProvide documentation of underlying diagnosis, objective measurements (PaCO2, sleep oximetry, MIP, FVC), and that RAD/CPAP are inappropriate or will not be used; submit documented criteria for initial and continued coverage.

SourceLink

POLICY UPDATE CHANGES

CPT/HCPCS code E0468 was added to the policy.

References reviewed and updated during annual review.

4Key covered indications referenced (restrictive thoracic disorders, COPD, invasive ventilation, backup ventilator)

4Explicit objective thresholds (PaCO2, O2 sat, MIP, FVC)

Coverage Summary

This policy defines medical necessity criteria for noninvasive and invasive home ventilators for Medicare members/enrollees and is covered with criteria when the documented clinical thresholds and requirements are met. It aligns with CMS National Coverage Determination Durable Medical Equipment Reference List, Ventilators (NCD 280.1) and Local Coverage Determination Respiratory Assist Devices (LCD L33800), and is informed by the AHRQ 2020 Technology Assessment. The policy is CURRENT and addresses key covered indications including restrictive thoracic disorders, COPD, invasive ventilation, and backup ventilators.

Medical Necessity — Initial and Continued Use

Initial use — Noninvasive home ventilator for restrictive thoracic disorders (first 3 months)

Covered when ALL of the following are met:

ALL of the following

ONE of
- An arterial blood gas partial pressure of carbon dioxide (PaCO2) measured while awake and breathing room air or on prescribed oxygen with PaCO2 ≥ 45 mm HgPaCO2 ≥ 45 mm Hg
- Sleep oximetry demonstrates O2 saturation ≤ 88% for at least five minutes while breathing prescribed O2O2 saturation ≤ 88% for ≥ 5 minutes
- ANY of the following
  - Maximal inspiratory pressure < 60 cm H2O< 60 cm H2O
  - Forced vital capacity < 50% predicted< 50% predicted

ALL of the following

Member/enrollee could not be appropriately treated with a respiratory assist device (RAD)
The noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

Chronic obstructive pulmonary disease (COPD) does not contribute significantly to the pulmonary limitation

Initial use — Noninvasive home ventilator for chronic respiratory failure due to COPD (first 3 months)

Covered when ALL of the following are met:

An arterial blood gas PaCO2 measurement done while awake and breathing at baseline and prescribed FIO2 is ≥ 52 mm HgPaCO2 ≥ 52 mm Hg

Prior to initiating therapy, sleep apnea and treatment with a CPAP device has been considered and ruled out (formal sleep testing not required if medical record documents that sleep apnea is not the predominant cause of awake hypercapnia or nocturnal arterial oxygen desaturation)

ALL of the following

Member/enrollee could not be appropriately treated with a respiratory assist device (RAD)
The noninvasive home ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

Continued use after initial 3-month certification period (noninvasive)

Covered when ALL of the following are documented:

Device is used for at least an average of four hours per 24-hour periodaverage ≥ 4 hours per 24-hour period

ALL of the following

Ongoing benefits from use of the device
The noninvasive home ventilator is not being used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

Overlap syndromes (noninvasive)

Requirement:

Presence of more than one condition (e.g., COPD and sleep apnea) requires secondary review by a medical director

Invasive ventilator — initial and ongoing use

Covered when:

Medically necessary for a long-term/chronic condition or disease affecting the ability to effectively maintain adequate respiratory status (examples: neuromuscular disease, thoracic restrictive disease, or chronic respiratory failure following COPD)

Second or back-up ventilator

A second or backup ventilator is considered medically necessary when ONE of the following is met:

A second ventilator to serve a different purpose from the first ventilator based on medical needs (e.g., negative pressure ventilator with chest shell for one indication and a positive pressure ventilator with nasal mask for the rest of the day)

A back-up ventilator when member/enrollee is confined to a wheelchair and requires a wheelchair-mounted ventilator during the day and another ventilator of the same type for use while in bed because positioning prevents use of the wheelchair-mounted ventilator while sleeping

A back-up ventilator when the member/enrollee resides in remote areas with poor emergency access

Provider Actions and Billing Guidance

Documentation Required

Document diagnostic criteria and alternatives

Provide documentation of the underlying diagnosis (neuromuscular disease or severe thoracic cage abnormality), objective measurements (PaCO2, sleep oximetry, maximal inspiratory pressure, forced vital capacity), and that a respiratory assist device (RAD) or CPAP is inappropriate or will not be used; for COPD patients document consideration and ruling out of CPAP.

Underlying diagnosis (e.g., neuromuscular disease or severe thoracic cage abnormality)
Objective measurements: PaCO2, sleep oximetry, MIP, FVC
Documentation that RAD/CPAP are inappropriate or will not be used
For COPD, documentation that CPAP was considered and ruled out

Prior Authorization

Initial and continued coverage require documentation review

Initial requests for noninvasive home ventilators and requests to continue use after the initial three-month certification period require submission of the documented medical necessity criteria (objective measurements and documentation that RAD/CPAP are inappropriate or will not be used). Overlap syndromes require secondary medical director review.

Documentation Required

Usage monitoring for continued coverage

For continued coverage beyond the initial three months, document the device is used at least an average of four hours per 24-hour period and that the member receives ongoing clinical benefit from the device; also document it is not being used to provide RAD or CPAP therapy.

Average use ≥ 4 hours per 24-hour period
Documentation of ongoing clinical benefit
Statement that device is not used to provide RAD/CPAP

Billing Rule

Use appropriate HCPCS code for ventilator type

When claiming reimbursement, report the specific HCPCS code that corresponds to the ventilator type.

E0465
E0466
E0467
E0468

Denial Risk

Denial risk if RAD/CPAP alternatives not documented

Claims may be denied if the documentation does not support that the member could not be appropriately treated with a RAD or that the device will not be used to provide RAD or CPAP therapy.

Prior Authorization

Secondary review for overlap syndromes

Cases with overlap syndromes (presence of more than one condition, e.g., COPD and sleep apnea) must be submitted for secondary review by a medical director prior to approval.

Background and Definitions

This policy follows NCD 280.1 and LCD L33800 and cites the AHRQ 2020 Technology Assessment as a supporting evidence review for its criteria. Per the AHRQ assessment and CMS sourcing, noninvasive home ventilation is preferred when feasible because it offers advantages over other settings, including lower cost, greater independence, improved quality of life, and decreased infection risk. The policy distinguishes noninvasive home ventilators by their ability to deliver variable airway pressures to reach a targeted tidal volume and reserves invasive ventilation for long-term support when ventilatory needs exceed the patient’s ability or airway protection is required.

Term	Definition
Noninvasive ventilation (NIV)	Administration of positive pressure to the lungs using interfaces such as nasal masks, orofacial masks, full face masks, mouthpieces, nasal pillows, or helmets.
Invasive ventilatory support	Administration of positive pressure to the lungs through an invasive interface, such as a tracheostomy tube or endotracheal tube.
RAD	Respiratory assist device; alternative support such as BiPAP or CPAP where appropriate.

Primary coverage sources informing this policy include: NCD Durable Medical Equipment Reference List (280.1); LCD Respiratory Assist Devices (L33800); and the AHRQ 2020 Technology Assessment.

OpenPayer

Home Ventilators

Coverage Summary

Medical Necessity — Initial and Continued Use

Codes and Billing

Provider Actions and Billing Guidance

Background and Definitions

Medicare Determinations

Revision History

E0465	Home ventilator, any type, used with invasive interface (e.g., tracheostomy tube)
E0466	Home ventilator, any type, used with noninvasive interface (e.g., mask, chest shell)
E0467	Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation; includes all accessories, components and supplies for all functions
E0468	Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation; includes all accessories, components and supplies for all functions

Name	Number	Type	Effective Date
Durable Medical Equipment Reference List, Ventilators	280.1	NCD	2003-04-01
Respiratory Assist Devices	L33800	LCD	2015-10-01